Decrease in agonist affinity for human platelet thromboxane A2/prostaglandin H2 receptors induced by a platelet-derived supernatant.

[1]  P. Halushka,et al.  Identification of a putative thromboxane A2/prostaglandin H2 receptor in human platelet membranes. , 1986, The Journal of biological chemistry.

[2]  P. Halushka,et al.  Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets. , 1985, The Journal of pharmacology and experimental therapeutics.

[3]  A. M. Lefer,et al.  Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. , 1985, The Journal of pharmacology and experimental therapeutics.

[4]  P. Halushka,et al.  Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors. , 1985, The Journal of pharmacology and experimental therapeutics.

[5]  T. Pugsley,et al.  A rapid filtration assay for soluble receptors using polyethylenimine-treated filters. , 1983, Analytical biochemistry.

[6]  J. Hanoune,et al.  Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human platelets. , 1982, Biochemical and biophysical research communications.

[7]  A. Budzynski,et al.  Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. , 1981, The Journal of biological chemistry.

[8]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[9]  P. Halushka,et al.  Synthesis of thromboxane receptor antagonists with the potential to radiolabel with 125I , 1984 .